Next-generation AAV capsids hold key to developing life-changing therapies. With Todd Carter.

Next gen AAV: How Can Synthetic Capsids Tackle Gene Therapy ChallengesПодробнее

Antigen Capsid-Incorporation for Development of Ad5-Vectored Vaccine | Protocol PreviewПодробнее

AAVCOVID: COVID-19 VaccineПодробнее

Discovering the Next Generation AAV Vector- Capsid Engineering & Expression Cassette OptimizationПодробнее

Meet electroCore's Dan GoldbergerПодробнее

Novel brain penetrant capsids for Parkinson’s disease gene therapyПодробнее

Overcoming the blood-brain barrier for gene therapy delivery with AAV capsids. With Amy Pooler, PhD.Подробнее

AAV Capsid EngineeringПодробнее

CORY NICHOLAS- FPRF ScientistПодробнее

On The Issue: Next Gen SequencingПодробнее

ASGCT 2022 Presentation PreviewПодробнее

AAV Services for Gene Therapy - Virtual EventПодробнее

CRISPR Corner 🧬 Episode 3 - How is DNA repaired after CRISPR cutting?Подробнее

Strategies for Development of Next-Gen AAVsПодробнее

Voyager TherapeuticsПодробнее

AAV Vector Shedding Assay—Best Practices in Clinical Gene Therapy Method DevelopmentПодробнее

Voyager TherapeuticsПодробнее

AGD 2020 - Session 3: Next generation cytogenetics by Alex HoischenПодробнее